306 related articles for article (PubMed ID: 35887277)
1. The Origin and Biomedical Relevance of Cannabigerol.
Jastrząb A; Jarocka-Karpowicz I; Skrzydlewska E
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887277
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.
Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C
Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
4. Direct Quantitation of Phytocannabinoids by One-Dimensional
Dadiotis E; Mitsis V; Melliou E; Magiatis P
Molecules; 2022 May; 27(9):. PubMed ID: 35566314
[TBL] [Abstract][Full Text] [Related]
5. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
Blebea NM; Pricopie AI; Vlad RA; Hancu G
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
[TBL] [Abstract][Full Text] [Related]
6. The Pharmacological Case for Cannabigerol.
Nachnani R; Raup-Konsavage WM; Vrana KE
J Pharmacol Exp Ther; 2021 Feb; 376(2):204-212. PubMed ID: 33168643
[TBL] [Abstract][Full Text] [Related]
7. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review.
Welling MT; Deseo MA; Bacic A; Doblin MS
Phytochemistry; 2022 Sep; 201():113282. PubMed ID: 35718133
[TBL] [Abstract][Full Text] [Related]
8. Cis-Δ
Tolomeo F; Russo F; Kaczorova D; Vandelli MA; Biagini G; Laganà A; Capriotti AL; Paris R; Fulvio F; Carbone L; Perrone E; Gigli G; Cannazza G; Citti C
J Pharm Biomed Anal; 2022 Sep; 219():114958. PubMed ID: 35930832
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota.
Luz-Veiga M; Amorim M; Pinto-Ribeiro I; Oliveira ALS; Silva S; Pimentel LL; Rodríguez-Alcalá LM; Madureira R; Pintado M; Azevedo-Silva J; Fernandes J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768709
[TBL] [Abstract][Full Text] [Related]
11. Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models.
Bęben D; Siwiela O; Szyjka A; Graczyk M; Rzepka D; Barg E; Moreira H
Curr Issues Mol Biol; 2024 Apr; 46(4):3626-3639. PubMed ID: 38666957
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives.
Calapai F; Cardia L; Esposito E; Ammendolia I; Mondello C; Lo Giudice R; Gangemi S; Calapai G; Mannucci C
Evid Based Complement Alternat Med; 2022; 2022():3336516. PubMed ID: 36397993
[TBL] [Abstract][Full Text] [Related]
13. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
Deiana S; Watanabe A; Yamasaki Y; Amada N; Arthur M; Fleming S; Woodcock H; Dorward P; Pigliacampo B; Close S; Platt B; Riedel G
Psychopharmacology (Berl); 2012 Feb; 219(3):859-73. PubMed ID: 21796370
[TBL] [Abstract][Full Text] [Related]
14. Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation.
Amstutz K; Schwark WS; Zakharov A; Gomez B; Lyubimov A; Ellis K; Venator KP; Wakshlag JJ
J Vet Pharmacol Ther; 2022 May; 45(3):245-254. PubMed ID: 35246858
[TBL] [Abstract][Full Text] [Related]
15. Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis.
Sanchez L; Baltensperger D; Kurouski D
Anal Chem; 2020 Jun; 92(11):7733-7737. PubMed ID: 32401504
[TBL] [Abstract][Full Text] [Related]
16. Development of a Rapid LC-MS/MS Method for the Quantification of Cannabidiol, Cannabidivarin, Δ
Piscitelli F; Pagano E; Lauritano A; Izzo AA; Di Marzo V
Anal Chem; 2017 Apr; 89(8):4749-4755. PubMed ID: 28343385
[TBL] [Abstract][Full Text] [Related]
17. Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID.
Ibrahim EA; Gul W; Gul SW; Stamper BJ; Hadad GM; Abdel Salam RA; Ibrahim AK; Ahmed SA; Chandra S; Lata H; Radwan MM; ElSohly MA
Planta Med; 2018 Mar; 84(4):250-259. PubMed ID: 29237190
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Strategies for Rare Cannabinoids Derived from
Nguyen GN; Jordan EN; Kayser O
J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
